CSTONE PHARMACEUTICALS by CSTONE PHARMACEUTICALS (CSPHF) Stock Price, Quote, News & History

CSPHFOTCPK

Trade with Public

$0.7000

Last update: Aug 10, 10:28 AM

OverviewNews Financials Sentiment Compare

Key Statistics

Open

Volume / Avg.

0 / 64.35K

Day Range

- - -

52 Wk Range

0.59 - 1.01

Market Cap

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

816.49

Recent CStone Pharmaceuticals News

Pfizer's Cancer Drug Partner Mulls Sale: Report

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-327.75M

Investing Cash Flow (TTM)

133.99M

Financing Cash Flow (TTM)

577.78M

Free Cash Flow (TTM)

-327.75M

Capital Expenditure (TTM)

Net Change in Cash (TTM)

384.02M

Valuation Metrics

Enterprise Value

$1.02B

PE Ratio (TTM)

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

16.51

PB Ratio (TTM)

5.80

Earnings Yield % (TTM)

-5.74%

Earnings Yield % (FWD)

EV / EBITDA (TTM)

Price / EBITDA (TTM)

Price / Free Cash Flow (TTM)

Book Value / Share

$0.12

Company Debt

Total Debt

$342.40M

LT Debt

$156.50M

LT Debt Issuance (TTM)

$265.00M

LT Debt Repayment (TTM)

-$240.80M

Total Cash

$753.70M

Debt to Equity

0.28

Issuance of Debt (TTM)

$24.20M

Repayment of Debt (TTM)

-$240.80M

Key Statistics

Open

Volume / Avg.

0 / 64.35K

Day Range

- - -

52 Wk Range

0.59 - 1.01

Market Cap

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

816.49

About

Sector

Health Care

Industry

Biotechnology

CStone Pharmaceuticals is engaged in developing and commercializing immuno-oncology and molecularly targeted drugs to address unmet medical needs in cancer treatment. The Group has been operating in one reportable segment, being the research and deve...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

CSPHF

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

CSPHF

FAQ

How do I buy CSTONE PHARMACEUTICALS by CSTONE PHARMACEUTICALS (CSPHF) stock?

You can purchase shares of CSTONE PHARMACEUTICALS by CSTONE PHARMACEUTICALS (OTCPK:CSPHF) through any online brokerage.

View our list of the best stock brokerages

Who are CSTONE PHARMACEUTICALS by CSTONE PHARMACEUTICALS (CSPHF) competitors?

There are no as such competitors for CSTONE PHARMACEUTICALS by CSTONE PHARMACEUTICALS.

What is the forecast, or price target, for CSTONE PHARMACEUTICALS by CSTONE PHARMACEUTICALS (CSPHF) stock?

There is no analysis for CSTONE PHARMACEUTICALS by CSTONE PHARMACEUTICALS to provide a consensus price target.

What is the current price for CSTONE PHARMACEUTICALS by CSTONE PHARMACEUTICALS (CSPHF)?

The stock price for CSTONE PHARMACEUTICALS by CSTONE PHARMACEUTICALS (OTCPK: CSPHF) is $0.7 last updated August 10, 2026 at 10:28 AM EDT.

Does CSTONE PHARMACEUTICALS by CSTONE PHARMACEUTICALS (CSPHF) pay a dividend?

There are no upcoming dividends for CSTONE PHARMACEUTICALS by CSTONE PHARMACEUTICALS.

When is CSTONE PHARMACEUTICALS by CSTONE PHARMACEUTICALS (OTCPK:CSPHF) reporting earnings?

CSTONE PHARMACEUTICALS by CSTONE PHARMACEUTICALS does not have any upcoming earnings scheduled.

Is CSTONE PHARMACEUTICALS by CSTONE PHARMACEUTICALS (CSPHF) going to split?

There is no upcoming split for CSTONE PHARMACEUTICALS by CSTONE PHARMACEUTICALS.

What sector and industry does CSTONE PHARMACEUTICALS by CSTONE PHARMACEUTICALS (CSPHF) operate in?

CSTONE PHARMACEUTICALS by CSTONE PHARMACEUTICALS is in the Health Care sector and Biotechnology industry. They are listed on the OTCPK.